Toward clinical translation of carbon nanomaterials in anticancer drug delivery: the need for standardisation
{{output}}
Carbon nanomaterials (CNMs), including graphene, carbon nanotubes, and carbon dots, have attracted considerable interest as nanocarriers for drug delivery due to their unique physicochemical properties. Their high surface area, biocompatibility, and modifiable... ...
